KEGG   PATHWAY: eai04650
Entry
eai04650                    Pathway                                
Name
Natural killer cell mediated cytotoxicity - Equus asinus (ass)
Description
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class
Organismal Systems; Immune system
Pathway map
eai04650  Natural killer cell mediated cytotoxicity
eai04650

Other DBs
GO: 0042267
Organism
Equus asinus (ass) [GN:eai]
Gene
106822180  FAS; tumor necrosis factor receptor superfamily member 6 isoform X2 [KO:K04390]
106822593  [KO:K02649]
106823692  SH2D1B; SH2 domain-containing protein 1B [KO:K07989]
106823831  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
106824521  NCR2; natural cytotoxicity triggering receptor 2 isoform X1 [KO:K06742]
106824699  [KO:K05414]
106824700  [KO:K05414]
106824701  [KO:K05414]
106824784  [KO:K05414]
106824785  [KO:K05414]
106824786  [KO:K05414]
106824973  HRAS; GTPase HRas isoform X1 [KO:K02833]
106824993  PIK3R2; LOW QUALITY PROTEIN: phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
106825034  TNF; tumor necrosis factor isoform X1 [KO:K03156]
106825037  NCR3; natural cytotoxicity triggering receptor 3 isoform X3 [KO:K06743]
106825548  KRAS; GTPase KRas isoform X2 [KO:K07827]
106825560  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
106825837  SH3BP2; SH3 domain-binding protein 2 isoform X2 [KO:K07984]
106825844  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
106826120  [KO:K04722]
106827306  [KO:K06856]
106827371  VAV3; guanine nucleotide exchange factor VAV3 [KO:K05730]
106827588  FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983]
106827902  [KO:K06464]
106828029  [KO:K01353] [EC:3.4.21.79]
106828030  [KO:K01353] [EC:3.4.21.79]
106828271  [KO:K05414]
106828272  [KO:K05415]
106828340  PPP3R1; calcineurin subunit B type 1 isoform X1 [KO:K06268]
106828516  SHC1; SHC-transforming protein 1 isoform X3 [KO:K06279]
106829050  LCK; tyrosine-protein kinase Lck isoform X1 [KO:K05856] [EC:2.7.10.2]
106829097  LAT; linker for activation of T-cells family member 1 isoform X1 [KO:K07362]
106829262  [KO:K07992]
106829263  HCST; hematopoietic cell signal transducer isoform X1 [KO:K07988]
106829313  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
106829345  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
106829397  [KO:K07827]
106829913  SH2D1A; SH2 domain-containing protein 1A [KO:K07990]
106830081  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
106830292  GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364]
106830400  [KO:K01353] [EC:3.4.21.79]
106830406  [KO:K01353] [EC:3.4.21.79]
106830409  [KO:K01353] [EC:3.4.21.79]
106830410  [KO:K01353] [EC:3.4.21.79]
106830417  [KO:K01353] [EC:3.4.21.79]
106830640  PRF1; perforin-1 [KO:K07818]
106830991  [KO:K04366] [EC:2.7.11.1]
106831116  [KO:K06463]
106831788  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
106831918  ITGAL; integrin alpha-L isoform X1 [KO:K05718]
106832322  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
106832511  PTK2B; protein-tyrosine kinase 2-beta isoform X1 [KO:K05871] [EC:2.7.10.2]
106832766  VAV1; proto-oncogene vav [KO:K05730]
106832838  IFNGR2; interferon gamma receptor 2 [KO:K05133]
106832840  IFNAR1; interferon alpha/beta receptor 1 [KO:K05130]
106832843  IFNAR2; interferon alpha/beta receptor 2 isoform X1 [KO:K05131]
106832855  [KO:K05859] [EC:3.1.4.11]
106833890  [KO:K05414]
106834099  [KO:K06541]
106834100  [KO:K06541]
106834123  [KO:K06541]
106834144  [KO:K06541]
106834164  [KO:K05415]
106834179  [KO:K05415]
106834202  [KO:K05415]
106834253  SHC2; LOW QUALITY PROTEIN: SHC-transforming protein 2 [KO:K17447]
106834358  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
106834431  PPP3CA; LOW QUALITY PROTEIN: serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform [KO:K04348] [EC:3.1.3.16]
106834926  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446]
106835538  ICAM2; intercellular adhesion molecule 2 isoform X1 [KO:K06523]
106835567  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
106835678  NRAS; GTPase NRas [KO:K07828]
106835769  CD48; CD48 antigen [KO:K06479]
106835774  CD244; LOW QUALITY PROTEIN: natural killer cell receptor 2B4 [KO:K06582]
106836232  [KO:K07985]
106836299  [KO:K07985]
106836365  [KO:K07983]
106836695  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
106837196  IFNGR1; interferon gamma receptor 1 [KO:K05132]
106837205  [KO:K07986]
106837208  [KO:K07987]
106837209  [KO:K07986]
106837312  [KO:K07986]
106837315  [KO:K07986]
106837366  LCP2; lymphocyte cytosolic protein 2 isoform X1 [KO:K07361]
106837399  [KO:K06541]
106837401  [KO:K06541]
106837402  KLRK1; NKG2-D type II integral membrane protein [KO:K06728]
106837403  [KO:K06516]
106837585  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860]
106838100  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
106838625  SHC4; SHC-transforming protein 4 [KO:K17449]
106838669  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
106839441  BID; BH3-interacting domain death agonist isoform X1 [KO:K04726]
106839506  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
106839739  SYK; tyrosine-protein kinase SYK isoform X1 [KO:K05855] [EC:2.7.10.2]
106840141  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2 [KO:K02649]
106840518  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
106840602  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
106840859  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
106840912  [KO:K06741]
106840989  LAT2; linker for activation of T-cells family member 2 [KO:K26356]
106841026  CSF2; granulocyte-macrophage colony-stimulating factor [KO:K05427]
106841519  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
106841549  CD247; T-cell surface glycoprotein CD3 zeta chain isoform X1 [KO:K06453]
106841633  SHC3; LOW QUALITY PROTEIN: SHC-transforming protein 3 [KO:K17448]
106842252  PTPN11; tyrosine-protein phosphatase non-receptor type 11 isoform X1 [KO:K07293] [EC:3.1.3.48]
106842388  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X3 [KO:K04348] [EC:3.1.3.16]
106842544  [KO:K07360] [EC:2.7.10.2]
106842618  BRAF; serine/threonine-protein kinase B-raf isoform X8 [KO:K04365] [EC:2.7.11.1]
106842897  PAK1; serine/threonine-protein kinase PAK 1 isoform X1 [KO:K04409] [EC:2.7.11.1]
106842975  [KO:K06464]
106843591  IFNG; interferon gamma [KO:K04687]
106845198  [KO:K07293] [EC:3.1.3.48]
106845291  VAV2; LOW QUALITY PROTEIN: guanine nucleotide exchange factor VAV2 [KO:K05730]
106845632  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
106846070  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
106847048  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
106847314  PTPN6; tyrosine-protein phosphatase non-receptor type 6 isoform X1 [KO:K05697] [EC:3.1.3.48]
106847522  TNFSF10; tumor necrosis factor ligand superfamily member 10 isoform X2 [KO:K04721]
106847693  [KO:K04722]
106847712  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X4 [KO:K04348] [EC:3.1.3.16]
106847984  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
106848262  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
106848556  [KO:K01353] [EC:3.4.21.79]
106848588  [KO:K01353] [EC:3.4.21.79]
106848589  [KO:K01353] [EC:3.4.21.79]
106848592  [KO:K01353] [EC:3.4.21.79]
106848611  [KO:K01353] [EC:3.4.21.79]
106848613  [KO:K01353] [EC:3.4.21.79]
123275602  [KO:K04722]
123275657  [KO:K01353] [EC:3.4.21.79]
123278215  [KO:K06464]
123280233  [KO:K05414]
123280237  [KO:K05414]
123280245  [KO:K05414]
123280255  [KO:K05415]
123280259  [KO:K05414]
123280293  [KO:K05415]
123283066  [KO:K01353] [EC:3.4.21.79]
123285086  [KO:K07986]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Chiesa S, Tomasello E, Vivier E, Vely F.
  Title
Coordination of activating and inhibitory signals in natural killer cells.
  Journal
Mol Immunol 42:477-84 (2005)
DOI:10.1016/j.molimm.2004.07.030
Reference
  Authors
Maghazachi AA.
  Title
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  Journal
Pharmacol Rev 57:339-57 (2005)
DOI:10.1124/pr.57.3.5
Reference
  Authors
Vivier E, Nunes JA, Vely F.
  Title
Natural killer cell signaling pathways.
  Journal
Science 306:1517-9 (2004)
DOI:10.1126/science.1103478
Reference
  Authors
Colucci F, Di Santo JP, Leibson PJ.
  Title
Natural killer cell activation in mice and men: different triggers for similar weapons?
  Journal
Nat Immunol 3:807-13 (2002)
DOI:10.1038/ni0902-807
Reference
  Authors
Perussia B.
  Title
Signaling for cytotoxicity.
  Journal
Nat Immunol 1:372-4 (2000)
DOI:10.1038/80808
Reference
  Authors
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  Title
Activation of NK cell cytotoxicity.
  Journal
Mol Immunol 42:501-10 (2005)
DOI:10.1016/j.molimm.2004.07.034
Reference
  Authors
Djeu JY, Jiang K, Wei S.
  Title
A view to a kill: signals triggering cytotoxicity.
  Journal
Clin Cancer Res 8:636-40 (2002)
Reference
  Authors
Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  Title
Nature's TRAIL--on a path to cancer immunotherapy.
  Journal
Immunity 18:1-6 (2003)
DOI:10.1016/S1074-7613(02)00502-2
Reference
  Authors
Colonna M.
  Title
Fine-tuning NK cell responses: it's a family affair.
  Journal
Nat Immunol 6:961-2 (2005)
DOI:10.1038/ni1005-961
Reference
PMID:8942070
  Authors
Bonnema JD, Leibson PJ.
  Title
Signal transduction during NK cell activation.
  Journal
Chem Immunol 64:28-43 (1996)
Reference
  Authors
Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  Title
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  Journal
J Immunol 175:749-54 (2005)
DOI:10.4049/jimmunol.175.2.749
Reference
PMID:9143705
  Authors
Rao A, Luo C, Hogan PG.
  Title
Transcription factors of the NFAT family: regulation and function.
  Journal
Annu Rev Immunol 15:707-47 (1997)
DOI:10.1146/annurev.immunol.15.1.707
Reference
  Authors
Wu J, Lanier LL.
  Title
Natural killer cells and cancer.
  Journal
Adv Cancer Res 90:127-56 (2003)
DOI:10.1016/S0065-230X(03)90004-2
Reference
  Authors
Cerwenka A, Lanier LL.
  Title
Natural killer cells, viruses and cancer.
  Journal
Nat Rev Immunol 1:41-9 (2001)
DOI:10.1038/35095564
Reference
  Authors
Blott EJ, Griffiths GM.
  Title
Secretory lysosomes.
  Journal
Nat Rev Mol Cell Biol 3:122-31 (2002)
DOI:10.1038/nrm732
Reference
  Authors
Lieberman J.
  Title
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  Journal
Nat Rev Immunol 3:361-70 (2003)
DOI:10.1038/nri1083
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Reference
  Authors
Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  Title
Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  Journal
Proc Natl Acad Sci U S A 102:123-7 (2005)
DOI:10.1073/pnas.0405737102
Reference
PMID:9862693
  Authors
Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  Title
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  Journal
J Immunol 161:6648-56 (1998)
Reference
  Authors
Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  Title
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  Journal
J Immunol 166:7219-28 (2001)
DOI:10.4049/jimmunol.166.12.7219
Related
pathway
eai04010  MAPK signaling pathway
eai04020  Calcium signaling pathway
eai04060  Cytokine-cytokine receptor interaction
eai04210  Apoptosis
eai04630  JAK-STAT signaling pathway
KO pathway
ko04650   

DBGET integrated database retrieval system